0.011990 0.000000 0.000000 0.000000 0.008292 0.000000 0.000000 0.000000 0.026525 0.00000 0.00000 0.00000 SER 37 - PRO 38 OMEGA = 96.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION CIS PROLINE - PRO 91 Acharya, K.R. Allen, S. Shapiro, R. Riordan, J.F. Vallee, B.L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 83.400 120.600 37.700 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 91 2915 2919 10.1073/pnas.91.8.2915 8159679 Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease. 1994 UK J.Mol.Biol. JMOBAK 0070 0022-2836 228 1269 Crystallization and Preliminary X-Ray Analysis of Human Angiogenin 1992 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 x-ray 1 1.0 14169.036 ANGIOGENIN 1 man polymer no no QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTT CKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTT CKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli 3.34 63.21 repository Initial release Version format compliance Version format compliance 1 0 1995-04-20 1 1 2008-03-03 1 2 2011-07-13 Y 1994-01-18 REL GLN 1 n 1 GLN 1 A ASP 2 n 2 ASP 2 A ASN 3 n 3 ASN 3 A SER 4 n 4 SER 4 A ARG 5 n 5 ARG 5 A TYR 6 n 6 TYR 6 A THR 7 n 7 THR 7 A HIS 8 n 8 HIS 8 A PHE 9 n 9 PHE 9 A LEU 10 n 10 LEU 10 A THR 11 n 11 THR 11 A GLN 12 n 12 GLN 12 A HIS 13 n 13 HIS 13 A TYR 14 n 14 TYR 14 A ASP 15 n 15 ASP 15 A ALA 16 n 16 ALA 16 A LYS 17 n 17 LYS 17 A PRO 18 n 18 PRO 18 A GLN 19 n 19 GLN 19 A GLY 20 n 20 GLY 20 A ARG 21 n 21 ARG 21 A ASP 22 n 22 ASP 22 A ASP 23 n 23 ASP 23 A ARG 24 n 24 ARG 24 A TYR 25 n 25 TYR 25 A CYS 26 n 26 CYS 26 A GLU 27 n 27 GLU 27 A SER 28 n 28 SER 28 A ILE 29 n 29 ILE 29 A MET 30 n 30 MET 30 A ARG 31 n 31 ARG 31 A ARG 32 n 32 ARG 32 A ARG 33 n 33 ARG 33 A GLY 34 n 34 GLY 34 A LEU 35 n 35 LEU 35 A THR 36 n 36 THR 36 A SER 37 n 37 SER 37 A PRO 38 n 38 PRO 38 A CYS 39 n 39 CYS 39 A LYS 40 n 40 LYS 40 A ASP 41 n 41 ASP 41 A ILE 42 n 42 ILE 42 A ASN 43 n 43 ASN 43 A THR 44 n 44 THR 44 A PHE 45 n 45 PHE 45 A ILE 46 n 46 ILE 46 A HIS 47 n 47 HIS 47 A GLY 48 n 48 GLY 48 A ASN 49 n 49 ASN 49 A LYS 50 n 50 LYS 50 A ARG 51 n 51 ARG 51 A SER 52 n 52 SER 52 A ILE 53 n 53 ILE 53 A LYS 54 n 54 LYS 54 A ALA 55 n 55 ALA 55 A ILE 56 n 56 ILE 56 A CYS 57 n 57 CYS 57 A GLU 58 n 58 GLU 58 A ASN 59 n 59 ASN 59 A LYS 60 n 60 LYS 60 A ASN 61 n 61 ASN 61 A GLY 62 n 62 GLY 62 A ASN 63 n 63 ASN 63 A PRO 64 n 64 PRO 64 A HIS 65 n 65 HIS 65 A ARG 66 n 66 ARG 66 A GLU 67 n 67 GLU 67 A ASN 68 n 68 ASN 68 A LEU 69 n 69 LEU 69 A ARG 70 n 70 ARG 70 A ILE 71 n 71 ILE 71 A SER 72 n 72 SER 72 A LYS 73 n 73 LYS 73 A SER 74 n 74 SER 74 A SER 75 n 75 SER 75 A PHE 76 n 76 PHE 76 A GLN 77 n 77 GLN 77 A VAL 78 n 78 VAL 78 A THR 79 n 79 THR 79 A THR 80 n 80 THR 80 A CYS 81 n 81 CYS 81 A LYS 82 n 82 LYS 82 A LEU 83 n 83 LEU 83 A HIS 84 n 84 HIS 84 A GLY 85 n 85 GLY 85 A GLY 86 n 86 GLY 86 A SER 87 n 87 SER 87 A PRO 88 n 88 PRO 88 A TRP 89 n 89 TRP 89 A PRO 90 n 90 PRO 90 A PRO 91 n 91 PRO 91 A CYS 92 n 92 CYS 92 A GLN 93 n 93 GLN 93 A TYR 94 n 94 TYR 94 A ARG 95 n 95 ARG 95 A ALA 96 n 96 ALA 96 A THR 97 n 97 THR 97 A ALA 98 n 98 ALA 98 A GLY 99 n 99 GLY 99 A PHE 100 n 100 PHE 100 A ARG 101 n 101 ARG 101 A ASN 102 n 102 ASN 102 A VAL 103 n 103 VAL 103 A VAL 104 n 104 VAL 104 A VAL 105 n 105 VAL 105 A ALA 106 n 106 ALA 106 A CYS 107 n 107 CYS 107 A GLU 108 n 108 GLU 108 A ASN 109 n 109 ASN 109 A GLY 110 n 110 GLY 110 A LEU 111 n 111 LEU 111 A PRO 112 n 112 PRO 112 A VAL 113 n 113 VAL 113 A HIS 114 n 114 HIS 114 A LEU 115 n 115 LEU 115 A ASP 116 n 116 ASP 116 A GLN 117 n 117 GLN 117 A SER 118 n 118 SER 118 A ILE 119 n 119 ILE 119 A PHE 120 n 120 PHE 120 A ARG 121 n 121 ARG 121 A ARG 122 n 122 ARG 122 A PRO 123 n 123 PRO 123 A author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 3_555 -x,y,-z+1/2 crystal symmetry operation 0.0000000000 0.0000000000 18.8500000000 A O ASN 43 A O ASN 43 A N CYS 81 A N CYS 81 A N THR 80 A N THR 80 A O THR 97 A O THR 97 A N ARG 70 A N ARG 70 A O VAL 105 A O VAL 105 A N ALA 106 A N ALA 106 A O HIS 114 A O HIS 114 1 A A SER PRO 37 38 96.94 1 17.44 2.70 111.00 128.44 A A A N CA C GLN GLN GLN 1 1 1 N 1 4.29 0.50 120.30 124.59 A A A NE CZ NH1 ARG ARG ARG 5 5 5 N 1 -3.55 0.50 120.30 116.75 A A A NE CZ NH2 ARG ARG ARG 31 31 31 N 1 3.98 0.50 120.30 124.28 A A A NE CZ NH1 ARG ARG ARG 32 32 32 N 1 3.79 0.50 120.30 124.09 A A A NE CZ NH1 ARG ARG ARG 33 33 33 N 1 6.77 1.10 114.20 120.97 A A A CA CB SG CYS CYS CYS 39 39 39 N 1 4.48 0.50 120.30 124.78 A A A NE CZ NH1 ARG ARG ARG 66 66 66 N 1 -3.25 0.50 120.30 117.05 A A A NE CZ NH2 ARG ARG ARG 66 66 66 N 1 5.98 0.80 106.30 112.28 A A A CD1 CG CD2 TRP TRP TRP 89 89 89 N 1 -5.73 0.80 107.30 101.57 A A A CE2 CD2 CG TRP TRP TRP 89 89 89 N 1 3.02 0.50 120.30 123.32 A A A NE CZ NH1 ARG ARG ARG 101 101 101 N 1 -4.63 0.50 120.30 115.67 A A A NE CZ NH2 ARG ARG ARG 101 101 101 N 1 17.64 2.30 115.30 132.94 A A A CA CB CG LEU LEU LEU 115 115 115 N 1 A A NE2 CD2 HIS HIS 13 13 -0.074 0.011 1.373 1.299 N 1 A ASN 3 66.06 -32.45 1 A SER 4 -38.29 -20.23 1 A GLN 19 -96.17 -82.75 1 A ARG 66 49.89 -149.44 0.22 0.22 2.4 8.0 6609 1 0.0 2.4 8.0 0 993 0 0 993 0.015 3.51 model building X-PLOR refinement X-PLOR phasing X-PLOR ANGIOGENIN CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN REVEALS THE STRUCTURAL BASIS FOR ITS FUNCTIONAL DIVERGENCE FROM RIBONUCLEASE 1 N N A ASN 3 A ASN 3 HELX_P A TYR 14 A TYR 14 1 H1 12 A ARG 21 A ARG 21 HELX_P A ARG 33 A ARG 33 1 H2 13 A ASN 49 A ASN 49 HELX_P A GLU 58 A GLU 58 1 H3 10 A GLN 117 A GLN 117 HELX_P A PHE 120 A PHE 120 5 H4 4 disulf 2.021 A CYS 26 A SG CYS 26 1_555 A CYS 81 A SG CYS 81 1_555 disulf 2.005 A CYS 39 A SG CYS 39 1_555 A CYS 92 A SG CYS 92 1_555 disulf 2.002 A CYS 57 A SG CYS 57 1_555 A CYS 107 A SG CYS 107 1_555 HYDROLASE (VASCULARIZATION) HYDROLASE (VASCULARIZATION) A PRO 90 A PRO 90 1 A PRO 91 A PRO 91 7.62 ANGI_HUMAN UNP 1 1 P03950 MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAI CENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP 25 147 1ANG 1 123 P03950 A 1 1 123 3 3 anti-parallel anti-parallel anti-parallel anti-parallel A ASP 41 A ASP 41 A HIS 47 A HIS 47 A PHE 76 A PHE 76 A HIS 84 A HIS 84 A GLN 93 A GLN 93 A ARG 101 A ARG 101 A LEU 69 A LEU 69 A LYS 73 A LYS 73 A VAL 103 A VAL 103 A GLU 108 A GLU 108 A LEU 111 A LEU 111 A ASP 116 A ASP 116 Unknown 8 Unknown 10 A GLN 12 A GLN 12 8 1_555 A HIS 13 A HIS 13 8 1_555 A LYS 40 A LYS 40 8 1_555 A THR 44 A THR 44 8 1_555 A GLU 108 A GLU 108 8 1_555 A HIS 114 A HIS 114 8 1_555 A GLN 117 A GLN 117 8 1_555 A SER 118 A SER 118 8 1_555 A LYS 60 A LYS 60 10 1_555 A ASN 61 A ASN 61 10 1_555 A GLY 62 A GLY 62 10 1_555 A ASN 63 A ASN 63 10 1_555 A PRO 64 A PRO 64 10 1_555 A HIS 65 A HIS 65 10 1_555 A ARG 66 A ARG 66 10 1_555 A GLU 67 A GLU 67 10 1_555 A ASN 68 A ASN 68 10 1_555 A ASN 109 A ASN 109 10 1_555 20 C 2 2 21